Brookfield Corp’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17,697
Closed -$3.49M 689
2023
Q1
$3.49M Sell
17,697
-8,800
-33% -$1.81M 0.01% 354
2022
Q4
$5.36M Buy
+26,497
New +$5.18M 0.02% 259
2022
Q3
Sell
-7,285
Closed -$1.47M 711
2022
Q2
$1.47M Sell
7,285
-12,856
-64% -$2.74M 0.01% 462
2022
Q1
$4.56M Sell
20,141
-43,018
-68% -$10.1M 0.02% 280
2021
Q4
$17M Buy
63,159
+1,025
+2% +$254K 0.07% 91
2021
Q3
$15M Buy
62,134
+4,425
+8% +$1.12M 0.06% 103
2021
Q2
$13.7M Buy
57,709
+29,348
+103% +$6.69M 0.06% 104
2021
Q1
$6.21M Buy
28,361
+6,748
+31% +$1.35M 0.03% 149
2020
Q4
$3.78M Buy
21,613
+8,073
+60% +$1.39M 0.02% 202
2020
Q3
$2.19M Buy
13,540
+2,612
+24% +$414K 0.01% 232
2020
Q2
$1.56M Buy
+10,928
New +$1.51M 0.01% 247

Other funds holding LH

Brookfield Corp's LH Position: Q2 2023 in Review

Brookfield Corp sold out of Labcorp (LH) in Q2 2023, closing a stake of 17,697 shares — an estimated $3.49M sold.

Brookfield Corp first reported a position in LH in Q2 2020 and held it in 11 quarters. The position peaked at $17M in Q4 2021. 931 funds tracked by Wall St. Rank hold LH as of Q2 2023.

  • Brookfield Corp reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
  • Brookfield Corp sold 17,697 Labcorp shares in Q2 2023, an estimated $3.49M.
  • Brookfield Corp first reported a position in Labcorp in Q2 2020 and held it in 11 quarters.
  • Brookfield Corp's Labcorp position peaked at $17M in Q4 2021.
  • 931 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.